Electronic Health Records (EHR) data, a rich source for biomedical research, have been successfully used to gain novel insight into a wide range of diseases. Despite its potential, EHR is currently underutilized for discovery research due to it's major limitation in the lack of precise phenotype information. To overcome such difficulties, recent efforts have been devoted to developing supervised algorithms to accurately predict phenotypes based on relatively small training datasets with gold standard labels extracted via chart review. However, supervised methods typically require a sizable training set to yield generalizable algorithms especially when the number of candidate features, p, is large. In this paper, we propose a semi-supervised (SS) EHR phenotyping method that borrows information from both a small labeled data where both the label Y and the feature set X are observed and a much larger unlabeled data with observations on X only as well as a surrogate variable S that is predictive of Y and available for all patients, under a high dimensional setting. Under a working prior assumption that S is related to X only through Y and allowing it to hold approximately, we propose a prior adaptive semi-supervised (PASS) estimator that adaptively incorporates the prior knowledge by shrinking the estimator towards a direction derived under the prior. We derive asymptotic theory for the proposed estimator and demonstrate its superiority over existing estimators via simulation studies. The proposed method is applied to an EHR phenotyping study of rheumatoid arthritis at Partner's Healthcare.
Introduction
Electronic Health Records (EHRs) provide a large and rich data source for biomedical research with the aim to further our understanding of disease progression and treatment response. EHR data has been successfully used to gain novel insights into a wide range of diseases, with examples including diabetes (Brownstein et al., 2010) , rheumatoid arthritis (Liao et al., 2014) , inflammatory bowl disease , and autism (Doshi-Velez et al., 2014) . EHR is also a powerful discovery tool for identifying novel associations between genomic markers and multiple phenotypes through analyses such as phenome-wide association studies (Denny et al., 2010; Kohane, 2011; Wilke et al., 2011; Cai et al., 2018) .
Despite its potential, ensuring unbiased and powerful biomedical studies using EHR is challenging because EHR was primarily designed for patient care, billing and record keeping. Extracting precise phenotype information for individual patient requires manual medical chart review, an expensive and manual process that is not scalable for research studies. To overcome such difficulties, recent efforts including those from Informatics for Integrating Biology and the Bedside (i2b2) Yu et al., 2015, e.g.) and the Electronic Medical Records and Genomics (eMERGE) network (Newton et al., 2013; Gottesman et al., 2013) have been devoted to developing phenotyping algorithms to predict disease status using relatively small training datasets with gold standard labels extracted via chart review.
Various approaches to EHR phenotyping have been proposed. Supervised machine learning methods have shown to achieve robust performance across disease phenotypes and EHR systems (Carroll et al., 2012; Liao et al., 2015) . However, supervised methods typically require a sizable training set to yield generalizable algorithms especially when the candidate features, denoted by X, is of high dimension. One approach to overcome the high dimensionality is to consider unsupervised methods. Unfortunately, standard unsupervised methods such as clustering are likely to fail when the dimension of X is large but a majority of the features are unrelated to the phenotype of interest but possibly predictive of some other underlying subgroups. Recently, unsupervised methods based on "silver standard labels" have been proposed (Agarwal et al., 2016; Chakrabortty et al., 2017) . These methods leverage a surrogate outcome S, such as the count of International Classification of Diseases, Ninth Revision (ICD9) billing codes for the disease phenotype, that is highly predictive of the true binary phenotype status Y . Agarwal et al. (2016) provides no statistical justification for the proposed algorithm. Chakrabortty et al. (2017) showed that a regularized estimator constructed from an unlabeled subset consisting of those with extreme values of S can be used to make inference about the direction of β under single index models S ∼ f (α X, ) and Y ∼ g(β X). However, their approach requires strong prior assumptions on the relationship among Y , S, and X. Furthermore, the Chakrabortty et al. (2017) method cannot be directly used to predict Y using both S and X.
In this paper, we propose a semi-supervised (SS) method for estimating Y | (S, X ) that borrows information from both a small labeled data with n realizations of {Y, S, X} and a much larger unlabeled data with N observations on {S, X}, under a high dimensional setting with N p n. We consider a logistic phenotype model for Y | S, X, a single index model (SIM) for S | X, as well as a working prior assumption that S is independent of X given Y . We obtain the estimator through regularization with penalty functions reflecting the prior knowledge. When the prior assumption holds exactly, we show that the unlabeled data can naturally be used to assist in the estimation of the phenotype model. Allowing the prior assumption to hold approximately, our prior adaptive semi-supervised (PASS) estimator adaptively incorporate the prior knowledge by shrinking the estimator towards a direction derived under the prior.
The proposed PASS estimator is similar to the prior LASSO (pLASSO) procedure of Jiang et al. (2016) in spirit in that both approaches aim to incorporate prior information into the 1 penalized estimator in a high-dimensional setting. The differences are, nevertheless, substantial and clear. Jiang et al. (2016) assumed that the prior information was summarized into prediction values and contributed to the likelihood term. In contrast, we use prior information to guide the shrinkage and put them into the penalty term. In this sense, PASS and pLASSO complement each other to some extent. However, as shown in both theory and simulations, putting prior information into the likelihood term tend to lead to the "take it or leave it" phenomenon: the usefulness of the prior information is determined based on the overall effect of all predictors. On the otherhand, by putting prior information into the penalty term, the PASS approach provides more flexible control: the data is able to scrutinize the individual effect of each predictor. This gained flexibility can result in improved theoretical and numerical performances.
The rest of this paper is organized as follows. We discuss the motivation, an important special scenario and the general methodology in Section 2. We analyze the theoretical properties of the proposed approach in Section 3, and access its finite sample performance via simulation studies in Section 4. Furthermore, we illustrate the practical value of the proposed approach on an EHR dataset regarding rheumatoid arthritis in Section 5. Finally, we conclude this paper with some discussions and extensions in Section 6. All technical proofs are given in the Supplementary Materials.
Methodology

Setup
We assume that the underlying data consists of N independent and identically distributed
where Y i is a binary indicator of the disease status of the ith patient, S i is a scalar surrogate variable that is reasonably predictive of Y i chosen via domain knowledge, and X i is a p-dimensional feature vector. Examples of S i includes the total count of ICD9 codes or NLP mentions for the disease of interest. Candidate features X may include the ICD9 code counts for competing diagnosis, lab results, as well as NLP mentions of relevant signs/symptoms, medications and procedures. We may also include various transformations of original features in X to account for nonlinear effects. While {W i , i = 1, ..., N } is fully observed, Y i is only observed for a random subset of n patients. Hence the observed data are L ∪ U , where without loss of generality, the first n observations are assumed fully observed as L = {(Y i , W i ) , i = 1, . . . , n}, and the rest constitute the unlabeled data as U = {W i , i = n + 1, . . . , N }.
Throughout
If J is a subset of {1, . . . , p}, then v J denotes a d-dimensional vector whose jth element is v j 1 j∈J , and 1 B is the indicator function for set B. The independence between random variables/vectors U and V is written as U ⊥ ⊥ V . We also denote the negative log-likelihood function associated with the logistic model with (y, η) = −yη + log(1 + e η ).
Model Assumptions
To predict Y using W = (S, X ) , we assume
To leverage data in U , we further assume a single index model (SIM) for S | X:
Here ζ 0 , γ 0 , β 0 and α 0 are parameters to be estimated. If α 0 and β 0 are similar in certain ways, one would expect that the unlabeled data U may be used to improve upon the standard supervised estimator for β 0 using L alone. For example, if S is a noisy representation of Y with random measurement error, then it's reasonable to assume that
Under (C prior ), we have Proposition 1 with proof given in Supplementary Materials.
Proposition 1. Under (M Y ), (M S ) and assume that (C prior ) holds, S and Y are positively correlated and it holds that: (C1) for any two vectors a 1 , a 2 , E(X a 2 |X a 1 ) is linear in X a 1 . Then we have α 0 = β 0 and α = kβ 0 for some scalar k > 0, where
Remark 1. The condition (C1) holds for elliptical distributions including multivariate normal. This is actually a mild assumption on the design in a high-dimensional setting, since low dimension projection of high dimensional distribution is nearly Gaussian, condition (C1) tends to hold at least approximately (Diaconis and Freedman, 1984; Hall and Li, 1993) .
Proposition 1 suggests that U can greatly improve the estimation of β 0 under (C prior ) because the phenotype model (M Y ) may be rewritten as logit Pr(Y = 1|S, X) = ζ + Sγ + ρX α for some ρ. Under this model, a simple SS estimator for ζ, γ and β in (M Y ) can be obtained as ζ, γ and ρ α, where (ζ, γ, ρ) is the minimizer of
By doing so, the direction of the high dimensional vector β is estimated based on the entire data L ∪ U , and only the parameters (ζ, γ, ρ) are estimated using the small labeled data L . Hereafter we shall refer to this SS estimator derived under (C prior ) as SS prior .
Nevertheless, SS prior is only valid when (C prior ) and (C1) holds exactly. Our goal is to develop a more robust SS estimator under (M Y ) and (M S ) that can efficiently exploit U when (C prior ) and (C1) may only hold approximately. In this more general setting, a desirable SS estimator should improve upon the standard supervised estimator when the directions of α 0 and β 0 are similar in their magnitude and/or support. In addition, it should perform similarly to the supervised estimator when the two directions are not close. We shall now detail our PASS estimation procedure which automatically adapts to different cases as reflected in the observed data.
Prior Adaptive Semi-Supervised (PASS) Estimator
With L only, a supervised estimator for β can be obtained via the standard 1 -penalized regression:
With properly chosen λ, the consistency and rate of convergence for ( ζ, γ, β ) has been established (van de Geer, 2008). To improve the estimation of β through leveraging U , we note that when (C prior ) holds approximately, the magnitude of β 0 − ρα 0 is small for some ρ, and the support of β 0 − ρα 0 is of small size as well.
To incorporate such prior belief on the relationship between α 0 and β 0 , we construct the penalty term min
The first term in the penalty measures how far β is from the closet vector along the α 0 direction, and hence encourages smaller magnitude of β − ρα 0 . The second term shrinks β A c 0 towards 0, which reflects our prior that predictors irrelevant to S are likely to be irrelevant to Y as well. The tuning parameters λ 1 , λ 2 control the strength of the belief imposed. When they are sufficiently large, β will be forced to be a multiple of α 0 and thus it ends up with the same estimator as in the case where (C prior ) holds.
Since we have N p samples to estimate α 0 , we use the adaptive LASSO penalized least square estimator α (Zou, 2006; Zou and Zhang, 2009) 
µ init and µ are tuning parameters that can be chosen via the cross-validation or Bayesian information criterion (BIC). Appending the penalty term (2) to the likelihood and replacing α 0 with its estimate α, we propose to estimate ζ, γ and β by
where A = supp( α). The estimators can be equivalently obtained as
The impact of the tuning parameters λ 1 , λ 2 can be understood from a bias-variance tradeoff viewpoint. When λ j 's are large, β tends to be a multiple of α and thus is an estimator with high bias and low variance. In contrast, when λ j 's are small, the likelihood term based on the labeled data L is the dominant part, and hence β will have low bias and high variance. By varying the values of λ j 's, we are able to obtain a continuum connecting these two extremes. In practice, λ 1 and λ 2 can be chosen via standard data-driven approaches such as the cross-validation.
Computation Details
The minimization in (3) can be solved with standard software for LASSO estimation. Let δ = β − ρ α. We can re-parametrize the expression above in terms of ζ, γ, ρ and δ as
where P = {1, . . . , p} and κ = λ 2 /λ 1 . This is a typical LASSO problem with covariates (1, S i , X i α, X i ) , parameters (ζ, γ, ρ, δ) , and a weighted 1 penalty on the parameters. Hence it can be solved by essentially any algorithm for adaptive LASSO fitting. In this paper, we use the R package glmnet (Friedman et al., 2010) to compute ζ, γ, ρ, and δ, and recover β by β = δ + ρ α.
Theoretical Properties
In this section, we will present non-asymptotic risk bounds for the PASS estimator that are valid with probability at least 1 − C for any arbitrary number > 0 and some constant C > 0. We also wish to make theoretical comparisons with the standard LASSO estimator to shed lights on when PASS outperforms the LASSO and where such improvement comes from. Throughout, We define
where α * is given by
Since the main results in this section depend on θ 0 solely through Z α * θ 0 , we will use θ 0 to represent any θ ∈ Θ 0 for simplicity. Following van de Geer and Muro (2014, Definitions 2.2 and 2.3), a random variable V is sub-Gaussian(τ 2 ) if E{exp(λ|V |)} ≤ 2 exp(λ 2 τ 2 /2) holds for all λ > 0. We assume α * 2 = 1 without loss of generality since α * is used to recover only the direction of β 0 in SIM and one can change ρ 0 correspondingly to make β 0 = δ 0 + ρ 0 α * invariant to α * 2 . We require two sets of assumptions with the first set being given below.
(A1) (Sub-Gaussian predictors and noise) There exists a constant B such that each predictor U j is sub-Gaussian(B 2 ) and the error term S − U ξ * is also sub-Gaussian(B 2 ). 
Remark 2. Assumption (A2) implicitly limits the magnitude of θ * and ensures that the distribution of Z α * | Y = 1 has sufficient overlap with that of Z α * | Y = 0. This assumption is weaker than the more common assumption that the probability π(Z α * θ 0 ) are bounded away from 0 and 1 almost surely, and is more suitable for EHR applications where extreme probabilities often occur. The nonlinear impact assumption (A3) describes to what extent the negative log-likelihood can be well approximated by a quadratic function in the neighborhood of θ 0 . It was first introduced by Belloni and Chernozhukov (2011) in the context of 1 -penalized quantile regression. This assumption is not needed if the probability π(Z α * θ 0 ) are assumed to be bounded away from 0 and 1 almost surely. Furthermore if Z α * are Gaussian or bounded, then assumption (A3) holds.
Remark 3. Assumptions (A4) and (A5) are used to establish estimation consistency and variable selection consistency of α. Assumption (A4) is common in the literature (see, e.g.
van de Geer and Bühlmann, 2009; Bickel et al., 2009 ). Note that we always require the index of intercept p + 1 ∈ Q * since it is not penalized. The minimum signal strength assumption similar to (A5) can be found at Zou and Zhang (2009) , e.g. One may note that (A5) is essentially stronger than the minimum signal strength assumption in existing literature like Zhao and Yu (2006) . In comparison with them, we do not require the irrepresentable condition that adds strong restriction on the correlation structure of the design matrix. In many semi-supervised settings such as typical EHR applications, (A5) is easily fulfilled because N is very large.
With θ = (δ , ρ, γ, ζ) , define that Ω(θ) = λ 0 (|ρ| + |γ| + |ζ|) + λ 1 δ A * 1 + λ 2 δ P\A * 1 , ∆ α = 2µ init q * /ϕ 2 and Π(θ) = |ρ|, where A * = supp(α * ) and λ 0 = 36B{log(6/ )/n} 1/2 . To introduce the oracle θ * , define
where 
, and β * = δ * + ρ * α * . Intuitively, one may view S + as the union of the set of unpenalized predictors and the set of predictors with large coefficients but not recovered by A * . While Scan be viewed as the union set of predictors with small nonzero coefficients and the predictors recovered by A * . Partitioning the support of θ into S + and Sis inspired by Bühlmann and Van De Geer (2011, Section 6.2.4), which leads to a refined bound.
Next, we introduce the second set of assumptions.
(A6) (Restricted eigenvalue for G) When S + ∩A * = ∅, there exists a constant φ > 0 such that
(A7) (Tuning parameters) Let q * be as defined in (A5). The tuning parameters for α
init . The tuning parameters for θ satisfy λ 1 ≥ 36B{log(2q * / )/n} 1/2 , and λ 2 ≥ 36B{log(2p/ )/n} 1/2 . Remark 4. One should also note that the constant φ in Assumption (A6) is not influenced by the collinearity of Z α * = (X , X α * , S, 1) since we rule that S + ∩ A * = ∅ and the subset of predictors corresponding to S + is non-singular. (A7) specifies the ranges for tuning parameters. The order of the tuning parameters are similar to those in the lasso literature (see, e.g. van de Geer and Bühlmann, 2009; Bickel et al., 2009 ). Existence of the tuning parameters µ and µ init in (A7) is guaranteed by (A5). Also note that we take λ 1 {log(q * )/n} 1/2 λ 2 {log(p)/n} 1/2 since the fitted support A recovers A * satisfying q * = |A * |+1. As one will see in Remarks 5-7, this actually plays an essential role in reducing the excess risk of the PASS estimator when the α * recovers the direction or support of β 0 .
(A8) regularizes the growth rate of N , n, p and |S * + |. The condition 64E (θ * , S * + , S * -) ≤ σ ensures that θ falls into a neighborhood of θ * and θ 0 where the negative log-likelihood can be well approximated by a quadratic function.
The following theorem establishes the risk bounds for the PASS estimator. Its proof can be found in the Supplementary Materials.
Theorem 1. For any > 0, if the assumptions (A1) -(A8) hold, the following inequalities hold simultaneously with probability at least 1 − 10 :
Linear prediction error:
Probability prediction error:
where Ξ = 64E (θ * , S * + , S * -).
The last term in Ξ = 64E (θ * , S * + , S * -) is of order O(λ 1 ∆ α |ρ * |), which reflects the estimation error in α. Assuming that N n and N log(p), which is the typical case in EHR applications, this term becomes negligible. While all the other terms in Ξ describe the estimation error in θ as if α is replaced with α * . To gain a better understanding of the key quantity Ξ in Theorem 1, we shall discuss several special cases in the following remarks.
Remark 5. Let ρ = min ρ β 0 − ρα * 1 , δ = β 0 − ρα * , θ = (δ , ρ, γ 0 , ζ 0 ) , S + = P and S -= supp(δ 0 ). Noting that G 1/2 (θ − θ 0 ) 2 = 0 and S + ∩ A * = ∅, we have Ξ = O{E (θ, S + , S -)} by the definition of θ * . Hence with large probability we have
where λ 0 = O(n −1/2 ), λ 1 = O{n −1/2 log(q * ) 1/2 } and λ 2 = O{n −1/2 log(p) 1/2 }. Hence, if δ 0 1 ≈ 0, then the excess risk of the PASS estimator achieves parametric convergence rate of Ξ = O(n −1 ), and the condition Ξ ≤ σ is trivially satisfied. Namely, if β 0 is very close to a multiple of α * , then the PASS estimator could outperform the vanilla LASSO estimator.
The gain is owing to the use of unlabeled data to obtain the direction of β 0 .
Remark 6. With the same choice of θ, S + and Sas in Remark 5. If one only have δ S-∩A * c 1 ≈ 0 but δ 0 1 ≈ 0, then the excessive risk of the PASS estimator satisfies
which is still better than the convergence rate of the excess risk for the supervised LASSO estimator as O{n −1/2 log(p) 1/2 δ S-∩A * 1 } when q * p. Namely, if α * might not recover the direction of β 0 very well but the prior information A * = supp(α * ) is sparse and covers supp(β 0 ) successfully, which is reflected as S + = P, the PASS estimator still benefits from the prior information.
In this situation, it is interesting to compare the proposed PASS estimator with the prior LASSO (pLASSO) procedure in Jiang et al. (2016) . While supp(α * ) and supp(β 0 ) are close while the magnitudes of α * and β 0 are quite different, the pLASSO procedure is unable to utilize this information and results in the same convergence rate as the LASSO estimator without any prior information, which is slower than the convergence rate of the PASS estimator. 
which means the excess risk of the PASS estimator is of the same order as that of the LASSO estimator. Also, the condition Ξ ≤ σ is satisfied as long as |B 0 | log(p)n −1 goes to zero, which means p can grows exponentially fast compared to n, while the exact rate depends on |B 0 |. Therefore the PASS approach is robust against low-quality prior information that recovers neither the direction nor the support of β 0 . This benefit is a result of using a data-adaptive parameter ρ to control the influence of the prior information on the estimator.
Finally, all the error bounds in Theorem 1 do not require that α * coincides with α 0 . Hence it justifies the usage of a working model for the estimation of α in the SIM (M S ).
Since in EHR applications the size of U is very large, throughout the paper we stick with linear regression as the working model to minimize the computation time for α. Based on our experiences, linear regression works quite well in the sense that the direction of α * is quite close to that of α 0 .
Simulation Studies
We conducted extensive simulation studies to examine the finite-sample performance of the PASS estimator and compare to existing estimators. Throughout, we let N = 10000 and p = 500. We use Bayesian information criterion (BIC) to select µ init and µ in the estimation of α due to large N , with ν = 1 in the adaptive LASSO weights, which allows us to estimate both the magnitude and support of α well. We use 10-fold cross validation to select λ 1 , λ 2 for the estimation of β, so that the phenotype model is tuned towards prediction performance.
We first generated each component of X i as X ij = h(Z ij ), where h(t) = log(1 + [e t ]), [u] denotes the integer nearest to u, and Z i = (Z i1 , . . . , Z ip ) follow a multivariate normal distribution N (0, Σ X ), where Σ Z = (σ i,j ) p i,j=1 and σ i,j = 4(0.5) |i−j| . One may think of [e Z ij ] as the counts of each billing code for the ith patient, which is often right skewed and hence transformed via t → log(1 + t) before analysis. The generation of X i mimics this process. We then generated S from S i = h(1 + X i α 0 + i ), where i ∼ N (0, 2 2 ). The disease status Y i was generated from logit Pr(Y i = 1 | S i , X i ) = −4 + 0.5S i + X i β 0 . Let Six scenarios with different relationships between α 0 and β 0 are considered: I: α 0 = (a 1 , a 2 , 0 p−10 ) , β 0 = 1.5(a 1 , a 2 , 0 p−10 ) ; II: α 0 = (a 1 , a 2 , 0 p−10 ) , β 0 = 1.5(a 1 + d 1 , a 2 + d 2 , 0 p−10 ) ; III: α 0 = (a 1 , a 2 , a 2 , a 2 , 0 p−10 ) , β 0 = 1.5(a 1 + d 1 , a 2 + d 2 , 0 p−10 ) ; IV: α 0 = (a 1 , 0 p−10 ) , β 0 = 1.5(a 1 + d 1 , a 2 + d 2 , 0 p−10 ) ; V: α 0 = (a 1 , a 2 , 0 p−10 ) , β 0 = 1.5(a 2 , a 1 , 0 p−10 ) ; VI: α 0 = (a 1 , a 2 , 0 p−10 ) , β 0 = 1.5(a 2 , 0 5 , a 1 , 0 p−15 ) .
Scenario I is the ideal case where β 0 and α 0 have identical direction. In Scenario II, most of the components of β 0 differ slightly from a scalar multiple of α 0 , while a few components differs substantially. Scenarios I and II are designed to examine the performance of PASS estimator when the prior information is highly or somewhat reliable. In Scenario III, α 0 is denser than β 0 and contains quite a few weak signals. On the contrary, in Scenario IV β 0 is denser than α 0 . In Scenario V, the magnitude of α 0 and β 0 are quite different, whereas they still share the same support. Scenarios III, IV and V are designed to examine the performance of PASS estimator with respect to different degree of accuracy of the support information. In Scenario VI, both the magnitude and the support of α 0 and β 0 differs substantially, which means the unlabeled data provides little information. This scenario allows us to see whether the PASS estimator is robust against unreliable prior information.
For comparison, we also implemented the following existing methods: (I) supervised learning via LASSO penalized logistic regression as in (1); (II) supervised learning via adaptive LASSO penalized logistic regression, denoted by ALASSO; (III) the SS prior estimator as described in section 2.2; (IV) the two variants of pLASSO estimator as proposed in Jiang et al. (2016) : (1) fit a logistic regression model with an 1 penalty imposed on predictors outside supp( α), as in equation (8) of their paper, and then use the predicted probability from that model as Y p i in equation (7) of their paper, denoted by pLASSO 1 ; (2) use the predicted probability given by the SS prior approach as Y p i in equation (7) of their paper, denoted by pLASSO 2 . For all methods including PASS, the label size n is indicated through the subscripts. For example, LASSO 100 refers to the LASSO method applied to n = 100.
For each scenario and method, the results are summarized using 1000 simulated datasets. To evaluate the prediction and estimation performance of the approaches mentioned above, for each simulated dataset we generate an independent test set of size 10000, and compute the area under the receiver operating characteristic curve (AUC), the excess risk (ER) as defined in Section 3, and the mean squared error of the predicted probabilities (MSE-P), which is the mean squared differences between the predicted probability and the true probability.
In Figures 1, we compare the methods with respect to the AUC, ER and MSE-P when n = 100. In Scenario I where the directions of β 0 and α 0 coincide, the SS prior approach performs the best as expected, yet the proposed PASS method attained very similar accuracy followed by pLASSO 2 which performed only slightly worse. When the directions of β 0 and α 0 are somewhat different as in Scenario II, the SS prior and the pLASSO estimators deteriorate quickly. In contrast, the PASS estimator maintains high accuracy and outperforms all competing estimators substantially. We observe qualitatively similar patterns for Scenarios III and IV under which α 0 and β 0 have somewhat different support. No matter whether α 0 is denser than β 0 as in Scenario IV, or β 0 is denser than α 0 as in Scenario V, the PASS method consistently outperforms the supervised estimators. Additionally, the performances of the SS prior and pLASSO approaches are not quite satisfactory. In Scenario V, β 0 and α 0 have the same support but are quite different in terms of magnitude. The proposed method managed to utilize the same-support information, whereas the pLASSO approaches failed to do so. Finally, the goal of Scenario VI is to examine the robustness of the methods when β 0 and α 0 differs a lot, possibly due to the use of an inappropriate surrogate. The PASS estimator performs similarly to the supervised estimators, indicating that our procedure is indeed adaptive to how well the data support the prior assumption. Across all scenarios, the ALASSO approach performs slightly worse than LASSO, possibly due to the presence of some small nonzero coefficients in β 0 .
In Figures 2, we present the AUC, ER and MSE-P of the PASS estimator trained with n = 100 and the supervised LASSO estimator with varying label size. In Scenario I where the prior assumption holds exactly, PASS 100 , the PASS approach with 100 labeled samples, even outperforms LASSO 400 , the LASSO approach with 400 labeled samples. When the prior assumption holds approximately as in Scenarios II through V, PASS 100 consistently outperforms LASSO 150 , and achieves similar performance as LASSO 200 , which requires twice as many labels. Finally, in Scenarios VI where the prior information is highly inaccurate, the PASS method maintains comparable performance against LASSO 100 .
Application to EHR Phenotying
We applied the proposed method to an EHR study conducted at Partner's Healthcare Systems. The goal of the study is to identify patients with rheumatoid arthritis (RA) based on their EHR features, including the number of ICD9 codes and the number of mentions of clinical terms related to RA extracted via natural language processing (NLP). This study cohort consists of N = 46114 patients who had at least 1 ICD9 code of RA or had been tested for RA, out of which a random subset of n = 435 patients have their true RA status determined via medical chart review by rheumatologists. We use the log count of ICD9 codes and NLP mentions of RA, denoted by N RA , as the surrogate. Here and in the sequel, we apply x → log(1 + x) transformation for all count variables. The additional EHR features consists of the number of clinical notes (N note ) which measures healthcare utilization and 923 NLP variables, N 1 , . . . , N 923 . Since patients with higher healthcare utilization tend to have higher counts of most features, we orthogonalize all features against N note and respectively define S, X 1 , ..., X 923 as the residual of N RA , N 1 , . . . , N 923 regressed against N note . The final feature set consist of the surrogate S and X = (X 1 , ..., X 923 , N note ) .
We apply the PASS approach, the SS prior approach, the supervised learning approaches including LASSO and ALASSO, as well as the pLASSO approaches to this dataset to build EHR phenotyping algorithms for identifying RA cases. We compute α using unlabeled data, and α has 166 nonzero components. For the comparison of supervised and semi-supervised methods, we sample n = 100 labeled observations for training and remaining labeled data to calculate out of sample accuracy. The pLASSO 1 is not included since the number of unpenalized parameters exceeds n. In Figure 3 , we report the average performance of the methods from 100 random partitions of the labeled data. Since the true parameter value is unknown, the ER and MSE-P are calculated by centering at the supervised LASSO estimate trained using all 435 labels.
The PASS method outperforms the supervised learning approaches such as LASSO and ALASSO in terms of the out of sample AUC achieved. It can be seen from ER and MSE-P that though supervised learning approaches show reasonably good AUC, they suffer from heavy shrinkage and hence the predicted probabilities are much worse than methods utilizing prior information, including PASS, SS prior and pLASSO 2 approaches. Moreover, for ER and MSE-P the supervised learning approaches show variations almost twice as large as methods utilizing prior information. Finally, it is interesting to notice that SS prior and PASS performs equally well, which provides some evidence that the C prior condition holds at least approximately in this dataset. In conclusion, the incorporation of prior information from the unlabeled data can substantially improve and stabilize the prediction performance of phenotyping models in EHR applications.
Discussion
In this paper, we propose PASS, a high dimensional sparse estimator adaptively incorporating the prior knowledge from surrogate under a semi-supervised scenario commonly found in application fields like EHR analysis. The proposed PASS approach can substantially reduce the number of labeled samples required when the prior information α 0 is trustworthy, compared to the supervised approaches. The PASS approach is also robust against unreliable prior information, compared to existing pLASSO approach that also incorporates prior information.
One of the main challenge in our theoretical analysis comes from the colinearity of covariates (1, S i , X i α, X i ) due to the enrollment of ρ to leverage the prior information in α. We overcome this by properly constructing the oracle coefficients θ * and the restricted eigenvalue assumption (A6). The formulation of our problem falls into the missing data framework with missing completely at random. However, the missing probability approaches 1 as N → ∞. This together with the high dimensionality of X makes the theoretical justifications more challenging than those used in the standard missing data literature. Without prior assumptions of β 0 − ρα 0 being sparse in certain sense, the unlabeled data cannot directly contribute to the estimation of β 0 . Our proposed PASS procedure hinges on the sparsity of β 0 − ρα 0 to leverage the unlabeled data.
We have restricted the discussion to a single surrogate variable for simplicity. However, the proposed method can be easily extended to multiple surrogates. Specifically, consider K surrogates, denoted by S [1] , . . . , S [K] . Let α [k] be the ALASSO estimator regressing S [k] i against X i , A = ∪ K k=1 supp( α k ), S i = (S [1] i , . . . , S [K] i ) and ρ = (ρ [1] , . . . , ρ [K] ) . We can obtain an estimator for the model parameters as ζ, γ, ρ, β = arg min ζ,γ,ρ,β
Theoretical justification and finite sample performance of β under this setting warrant further research.
One may note that we require X to be elliptical, which is nearly restricted to multivariate normal distribution, to ensure that the SIM estimator α recovers the direction of β 0 under M Y , M S and C prior . This could limit the use of our method in practical settings like EHR study. To fix this issue, one can extend our method by replacing our estimation α with non-Gaussian design high dimensional SIM estimators like that proposed by ?. This proposal is particular suitable for our semi-supervised setting with a large amount of unlabelled samples since ? requires the knowledge of the probability density function of X.
